Additionally, antibodies against cell surface GRP78 have been developed with diverse mechanisms to induce cancer cell death and suppress GRP78-mediated oncogenic signaling(Lee 2014; Hernandez and Cohen 2022). Here, HSPA5 is linked to cancer.